Drug Type Antibody |
Synonyms |
Target |
Mechanism KRT19 inhibitors(Keratin 19 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | KR | 30 Jan 2022 | |
Pancreatic Cancer | Preclinical | KR | 30 Jan 2022 | |
Stomach Cancer | Preclinical | KR | 30 Jan 2022 |